|
NOP56 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.01105840050786E-13 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.21450000454016E-08 |
| Normal-vs-Stage2 |
7.897800E-03 |
| Normal-vs-Stage3 |
2.771600E-04 |
| Normal-vs-Stage4 |
1.278950E-03 |
| Stage1-vs-Stage2 |
9.456200E-01 |
| Stage1-vs-Stage3 |
9.883300E-03 |
| Stage1-vs-Stage4 |
1.900800E-03 |
| Stage2-vs-Stage3 |
1.623560E-02 |
| Stage2-vs-Stage4 |
1.856310E-02 |
| Stage3-vs-Stage4 |
6.129400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.19493345510591E-12 |
| Normal-vs-AfricanAmerican |
1.221820E-04 |
| Normal-vs-Asian |
8.765900E-02 |
| Caucasian-vs-AfricanAmerican |
3.405400E-01 |
| Caucasian-vs-Asian |
2.230800E-01 |
| AfricanAmerican-vs-Asian |
1.187380E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.96739990754713E-10 |
| Normal-vs-Female |
2.05660000140995E-08 |
| Male-vs-Female |
8.361500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.03919999999647E-05 |
| Normal-vs-Extreme_Weight |
2.94130000022541E-07 |
| Normal-vs-Obese |
2.68680000004018E-06 |
| Normal-vs-Extreme_Obese |
9.565800E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.830390E-01 |
| Normal_Weight-vs-Obese |
8.634600E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.615500E-04 |
| Extreme_Weight-vs-Obese |
1.011040E-01 |
| Extreme_Weight-vs-Extreme_Obese |
2.764200E-02 |
| Obese-vs-Extreme_Obese |
3.400600E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.827500E-04 |
| Normal-vs-Age(41-60Yrs) |
3.02190050760487E-10 |
| Normal-vs-Age(61-80Yrs) |
2.29030000520325E-08 |
| Normal-vs-Age(81-100Yrs) |
8.729000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.731900E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.913930E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.425800E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.074200E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.621740E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.856360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.17240012037701E-10 |
| Normal-VS-Type2 PRCC |
2.817700E-04 |
| Normal-VS-KIRP CIMP |
4.899700E-03 |
| Normal-VS-Unclassified PRCC |
1.417250E-03 |
| Type1 PRCC-VS-Type2 PRCC |
7.958600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
2.925600E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
1.451780E-01 |
| Type2 PRCC-VS-KIRP CIMP |
4.482700E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
1.862020E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.374970E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.357400E-04 |
| Normal-vs-N1 |
3.83390000000539E-05 |
| Normal-vs-N2 |
3.104600E-01 |
| N0-vs-N1 |
1.700060E-03 |
| N0-vs-N2 |
8.966400E-01 |
| N1-vs-N2 |
1.782180E-01 |
|
|
